Dermatology News

The city of Philadelphia has issued a formal apology for the experiments conducted by the University of Pennsylvania at Philadelphia’s Holmesburg Prison from the 1950s to 1970s, according to a press release.

The FDA has approved Dupixent for the treatment of prurigo nodularis in adults, Regeneron and Sanofi announced in a press release.

A 30-month-old male presents to your office for evaluation of some “blisters” on his right hand.

Online forums, chatrooms and communities are often able help patients with chronic illness find comfort by connecting with other patients sharing their disease burden.

This year, one of the presentations at November’s Infectious Diseases in Children Symposium will mark the end of an era.

The word “gaslighting” has taken on a life of its own in recent years, being used in the context of interpersonal relationships, political discourse and online chatter alike.

Adult patients with active psoriatic arthritis who received risankizumab reported sustained improvements in skin and joint symptoms at week 100 in two ongoing phase 3 trials, according to data released by AbbVie.

The FDA has approved Spevigo for the treatment of generalized pustular psoriasis, Boehringer Ingelheim announced in a press release.

Although they exhibit a greater risk for severe immune-related adverse effects, patients with preexisting autoimmune disease receiving immune checkpoint inhibitors for melanoma had better 2-year survival than controls, according to data.

Patients with psoriatic arthritis may consider tapering once treatment goals are reached, according to guidance from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis published in Nature Reviews Rheumatology.